Phathom Pharmaceuticals (PHAT) Leases (2022 - 2025)
Historic Leases for Phathom Pharmaceuticals (PHAT) over the last 4 years, with Q3 2025 value amounting to $2.7 million.
- Phathom Pharmaceuticals' Leases rose 22340.94% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year increase of 22340.94%. This contributed to the annual value of $613000.0 for FY2024, which is 5844.07% down from last year.
- According to the latest figures from Q3 2025, Phathom Pharmaceuticals' Leases is $2.7 million, which was up 22340.94% from $873000.0 recorded in Q2 2025.
- Phathom Pharmaceuticals' Leases' 5-year high stood at $2.7 million during Q3 2025, with a 5-year trough of $388000.0 in Q1 2025.
- In the last 4 years, Phathom Pharmaceuticals' Leases had a median value of $1.7 million in 2023 and averaged $1.6 million.
- Over the last 5 years, Phathom Pharmaceuticals' Leases had its largest YoY gain of 22340.94% in 2025, and its largest YoY loss of 6930.38% in 2025.
- Quarter analysis of 4 years shows Phathom Pharmaceuticals' Leases stood at $2.3 million in 2022, then tumbled by 35.51% to $1.5 million in 2023, then crashed by 58.44% to $613000.0 in 2024, then skyrocketed by 339.48% to $2.7 million in 2025.
- Its last three reported values are $2.7 million in Q3 2025, $873000.0 for Q2 2025, and $388000.0 during Q1 2025.